Merck

Daiichi Sankyo

Follow

Daiichi Sankyo, Inc. is the U.S. subsidiary of Daiichi Sankyo, Co., Ltd. Daiichi Sankyo, Inc. medicines approved in the U.S. include therapies for hypertension, pain management, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma.

Charles River Laboratories

Follow

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guides us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. Today, we operate more than 150 facilities in 21 countries and have worked on over 80% of the FDA-approved drugs over the last five years and 85% of FDA-approved drugs in 2023 alone. As a partner of choice for our clients’ nonclinical drug research and development needs, we differentiate ourselves through our broad portfolio, scientific expertise, global scale, and excellent service.

Regeneron

Follow

Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to 12 medicines approved in the United States and/or other countries and numerous product candidates in development, nearly all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic diseases, infectious diseases and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. We do not interview candidates on Google Hangouts. Any questions about job listings can be directed to candidatesupport@regeneron.com . We also do not hire for “at-home data entry” positions.

R&S Northeast, LLC

Follow

Family owned since 1973, R&S Northeast has been a supplier of various healthcare products, including Brand and Generic Pharmaceuticals, Medical and Surgical supplies, and Infection Control products.

Amgen

Follow

At Amgen, there is no choice but better.  Because going halfway will never get us to tomorrow. We’re transforming the promise of science and biotechnology into therapies that have the power to restore health. We leverage our global talent—22,000 scientists and professionals—to research, manufacture and deliver new medicines and reach millions of patients worldwide. Amgen is an equal opportunity employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status. See our Community Guidelines: http://bit.ly/smcgl